ABT · News · 20260821N
Guidance / Outlook
ABBOTT LABORATORIES · 2026-08-21 · Importance 51 · Surprise 60
Abbott reportedly raised its annual 2026 profit forecast after stronger-than-expected second-quarter results. The revised outlook was attributed primarily to demand for cancer diagnostics and medical devices. The reporting also cited continued competitive and pricing pressure in continuous glucose monitoring, creating an offset to the broader portfolio strength.